Literature DB >> 15127384

Repair of calvarial defects in rats by prefabricated hydroxyapatite cement implants.

H Schliephake1, R Gruber, M Dard, R Wenz, S Scholz.   

Abstract

The aim of the present study was to test the hypothesis that calvarial defects can be repaired by using preformed implants of calcium phosphate bone cement (CPBC) in rats. Sixty adult female Sprague-Dawley rats received full-thickness calvarial nonhealing defects with a diameter of 8 mm. Three different CPBCs were used: group 1: tetracalcium phosphate-based powder; group 2: a blend of amorphous and crystalline calcium phosphate precursors; and group 3: an alpha-tricalcium phosphate (alpha-TCP)-based powder. Implants were left to cure for 25-40 min at room temperature in a silicon mold of 7.9 mm and inserted press fit into the defects. Fifteen animals served as unfilled controls. After 13, 26, and 52 weeks, the material was analyzed qualitatively by using surface-stained undecalcified thick-section specimens and quantitatively by using semiautomated histometry. Kruskal-Wallis tests were applied to compare mean values of periimplant bone formation at a significance level of p < 0.05. Three implants of group 1 fractured during insertion. Resorption of CPBC without complementary bone formation was noticed in these implants. Unfractured implants were resorbed with simultaneous apposition of bone on the implant surface. After 52 weeks, the resorption rate varied between 23.1 and 39.3%. Periimplant bone formation increased continuously on average around all implant types, but it reached statistical significance only in group 2. The results showed that repair of calvarial defects can be achieved by preformed CPBC implants. The rate of resorption of preformed implants is, however, much lower than that reported for in vivo cured CPBC. Copyright 2004 Wiley Periodicals, Inc. J Biomed Mater Res 69A: 382-390, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127384     DOI: 10.1002/jbm.a.20121

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  4 in total

1.  Setting solution concentration effect on properties of a TTCP/DCPA-derived calcium phosphate cement.

Authors:  Chang-Keng Chen; Chien-Ping Ju; Jiin-Huey Chern Lin
Journal:  J Mater Sci Mater Med       Date:  2012-06-12       Impact factor: 3.896

2.  Preparation and properties of calcium phosphate cements incorporated gelatin microspheres and calcium sulfate dihydrate as controlled local drug delivery system.

Authors:  Shu Cai; Yujia Zhai; Guohua Xu; Shanshan Lu; Wei Zhou; Xiaojian Ye
Journal:  J Mater Sci Mater Med       Date:  2011-09-06       Impact factor: 3.896

3.  Creation of macroporous calcium phosphate cements as bone substitutes by using genipin-crosslinked gelatin microspheres.

Authors:  Meng Li; Xingyan Liu; Xudong Liu; Baofeng Ge; Keming Chen
Journal:  J Mater Sci Mater Med       Date:  2008-12-04       Impact factor: 3.896

4.  Morphology and mechanical behavior of TTCP-derived calcium phosphate cement subcutaneously implanted in rats.

Authors:  C H Tsai; C P Ju; J H Chern Lin
Journal:  J Mater Sci Mater Med       Date:  2008-01-10       Impact factor: 3.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.